Voyageur Pharmaceuticals
The Price of Security: When Critical Minerals Become Too Expensive
There is a contradiction at the heart of Western critical minerals policy that I think we are going…
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
Voyageur Pharmaceuticals’ X-Ray Contrast Media Provides a Dramatic Increase in Valuation
Assuming you aren’t a meme stock or an equity driven by the Reddit army, then you know you’ve…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on creating the first vertically integrated medical radiological contrast media supplier in NA
In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV:…
No CommentsInvestorNews
-
Canada’s Voyageur Pharmaceuticals Breaking a Chinese Monopoly
In a recent InvestorIntel interview, Jack Lifton spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd.…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals strategy is to remove the middleman and supply radiographic contrast media direct from mine to the X-ray center
Sourcing raw materials is one of today’s biggest problems, as a result companies are looking to have more…
No CommentsInvestorNews
-
Brent Willis on Voyageur Pharmaceuticals’ competitive suite of barium radiographic contrast media products
In a recent InvestorIntel interview, Chris Thompson speaks with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd.…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Supply Chain Security Advantage – From the Earth to the Bottle
With all the warnings issued in articles posted on InvestorIntel about rare earth supply security, the whole Suez…
No CommentsInvestorNews
-
High-Grade Barium Project Creates High-Value Opportunity for Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd. (TSXV: VM) (Voyageur) is a Canadian-based company that is focused on developing barium and iodine…
No CommentsInvestorNews
InvestorNews Member News
-
SERV, Swiss Export Risk Insurance, Supports Guarantee of USD 212.5 Million for Capex of First Phosphate Mine Project in Quebec, Canada
-
Renforth Resources to Attend the ArcStone Kingswood Growth Summit 2026 in Toronto
-
Nord Reports Updated Gowganda Tailings Indicated Mineral Resource of 2.814 Million Ounces of Silver at 47.4 g/t
-
Appia Expands Otherside Uranium Property by Staking Twenty (20) Additional Mineral Claims Following Positive MT Survey Results
-
Volta Drills 7.37% Rare Earth Oxide and 252.7 g/t Gallium Oxide over 1.5m at Springer
